1. Home
  2. BATRA vs TXG Comparison

BATRA vs TXG Comparison

Compare BATRA & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

HOLD

Current Price

$47.25

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$18.76

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BATRA
TXG
Founded
1991
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BATRA
TXG
Price
$47.25
$18.76
Analyst Decision
Buy
Hold
Analyst Count
2
14
Target Price
$57.00
$17.18
AVG Volume (30 Days)
48.9K
2.3M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
76.97
EPS
N/A
N/A
Revenue
N/A
$245,893,000.00
Revenue This Year
$12.40
N/A
Revenue Next Year
$8.54
$7.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
68.06
52 Week Low
$38.67
$6.78
52 Week High
$50.45
$23.56

Technical Indicators

Market Signals
Indicator
BATRA
TXG
Relative Strength Index (RSI) 53.94 41.65
Support Level $45.81 $11.62
Resistance Level $48.05 $20.62
Average True Range (ATR) 1.32 1.22
MACD -0.27 -0.28
Stochastic Oscillator 34.79 8.11

Price Performance

Historical Comparison
BATRA
TXG

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: